Literature DB >> 32588987

Prevalence, incidence and epidemiology of childhood uveitis.

Mira Siiskonen1,2,3,4, Iida Hirn2,3, Roosa Pesälä2,3, Timo Hautala5, Pasi Ohtonen3,4, Nina Hautala1,2,3,4.   

Abstract

PURPOSE: To analyse the prevalence, incidence and aetiology of paediatric uveitis.
METHODS: A retrospective, population-based cohort study of Finnish children with uveitis in Northern Ostrobothnia Hospital District in 2008-2017. The data included parameters for age, gender, age at diagnosis, laterality, chronicity, anatomical distribution of the disease, aetiology and systemic association.
RESULTS: One hundred fifty patients aged <16 years (mean age 6.9 ± 3.9 years) with uveitis were included, out of whom 53% were girls. The first uveitis episode occurred at 1-6 years in 59%, and 62% of them were girls. In the age group of 7-15 years, boys were diagnosed with uveitis more frequently than girls (61% versus 39%, respectively). Seventy percent of the girls were diagnosed with their first uveitis episode at the age of 1-6 years, whereas only 48% of the boys were diagnosed at that age. The prevalence of uveitis increased from 64/100 000 children <16 years in 2008 (95% CI, 47.7-84.2) to 106/100 000 in 2017 (95% CI, 84.6-130.2). The incidence of childhood uveitis in 2008-2017 was 14/100 000 person-years in children <16 years (95% CI, 11.3-16.5). Eighty-seven percent of the cases were non-infectious, 9% were infectious, and 3% had masquerade syndromes. Sixty-one percent of patients had juvenile idiopathic arthritis (JIA).
CONCLUSION: The prevalence of paediatric uveitis has increased during the last decade in both genders. Uveitis is more frequent in girls, and they were diagnosed at a younger age than boys. Idiopathic cases and JIA accounted for a majority of aetiological features.
© 2020 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.

Entities:  

Keywords:  childhood; epidemiology; incidence; prevalence; uveitis

Year:  2020        PMID: 32588987     DOI: 10.1111/aos.14535

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  6 in total

1.  Development of a Nationally Agreed Core Clinical Dataset for Childhood Onset Uveitis.

Authors:  Ameenat Lola Solebo; Salomey Kellett; Jugnoo Rahi; Reshma Pattani; Clive Edelsten; Andrew D Dick; Alastair Denniston
Journal:  Front Pediatr       Date:  2022-06-21       Impact factor: 3.569

2.  Pediatric Noninfectious Uveitis in a Tertiary Referral Center in Jordan: Clinical Spectrum and Immunomodulatory Treatment.

Authors:  Raed Alzyoud; Motasem Alsuwaiti; Hiba Maittah; Boshra Aladaileh; Mohammed Nobani; Ayman Farhan; Hadeel Alqurieny; Ahmed Khatatbeh; Zeyad Habahbeh
Journal:  Cureus       Date:  2022-06-11

3.  Follow-up Findings of Non-infectious Pediatric Uveitis Patients.

Authors:  Zahide Ekici Tekin; Gülçin Otar Yener; Selen Akbulut; Ebru Nevin Çetin; Selçuk Yüksel
Journal:  Turk J Ophthalmol       Date:  2021-12-28

Review 4.  Biological Therapy in Noninfectious Pediatric Uveitis: A Systematic Review.

Authors:  Luiz Fernando Norcia; Olívia Pereira Kiappe; Eliane Chaves Jorge
Journal:  Clin Ophthalmol       Date:  2021-09-07

5.  Tocilizumab and Abatacept for the Treatment of Childhood Chronic Uveitis: A Monocentric Comparison Experience.

Authors:  Ilaria Maccora; Sarah Abu Rumeileh; Franco Curci; Cinzia de Libero; Edoardo Marrani; Maria Vincenza Mastrolia; Ilaria Pagnini; Gabriele Simonini
Journal:  Front Pediatr       Date:  2022-04-12       Impact factor: 3.418

6.  Clinical benefits and potential risks of adalimumab in non-JIA chronic paediatric uveitis.

Authors:  Carlyn V Kouwenberg; Viera Koopman-Kalinina Ayuso; Joke H de Boer
Journal:  Acta Ophthalmol       Date:  2021-09-16       Impact factor: 3.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.